Navigation Links
Mid America Professional Group, PC and DENTCA, Inc. Renew Commitment to Providing High Quality Dentures to America’s Elderly Population
Date:12/10/2013

Los Angeles, CA (PRWEB) December 10, 2013

DENTCA, Inc. is happy to announce our renewed partnership with Mid America Professional Group, PC (MAPG) and our shared commitment to providing readily available, high quality dentures to America’s elderly population. As one of the earliest network-wide adopters of DENTCA’s digital CAD/CAM denture system, MAPG recognized the need for treating edentulous long term care facilities residents with a streamlined approach that is highly accurate, predictable, repeatable, and convenient. After testing DENTCA’s system in the field, MAPG implemented a centralized administration system to effectively manage the placement and delivery of all denture cases involving numerous dentists across multiple states.

Luis Garabis, DDS, Dental Director, Mid America Professional Group, PC, explains:

“DENTCA’s system has been a tremendous asset to our vision of providing not just convenient dentures, but quality dentures. With DENTCA’s CAD/CAM system, we know that our dentures are customized precisely for each patient to enhance comfort, durability, retention, and function. When treating elderly people who live in long term care facilities, each of these qualities are even more important because the denture enhances masticatory function and provides aesthetic results, thus improving the residents’ quality of life.”

“While the Holiday Season is a reminder that comes once a year about the celebrations of eating, smiling, laughing, and sharing memorable moments with family and friends, doctors who treat edentulous patients experience the overwhelming challenges edentulous people face every day. At MAPG, we are committed to solving these challenges that so many elderly face today by generating high quality prosthetics that are truly life-changing and add so much quality to everyone’s lives.”

The partnership between DENTCA and MAPG has helped both companies grow and find more efficien
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Clinical news alert from the American Academy of Orthopaedic Surgeons
2. American College of Cardiology cites new USF Simulation Center for Training Excellence
3. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
4. Young Americans Need to Cut Calorie Intake: Study
5. Hutchinson Center president elected to American Academy of Art and Sciences
6. Can weight loss help African-American breast cancer survivors?
7. Americans Support Medicare Reform, But Not on Their Dime: Poll
8. One-third of adult Americans with arthritis battle anxiety or depression
9. Equal access to care helps close survival gap for young African-American cancer patients
10. Systemic sclerosis complications more severe in African Americans than Caucasians
11. 53 million Americans might have diabetes by 2025, according to a new study in Population Health Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... 30, 2015 “ Milli the Snail ” ... which takes a look at the latest and coolest applications ... the host of AppWatch and technology expert, conducted the app ... game that engages and educates children. , Interactive mobile games ... all the content and games they are playing are doing ...
(Date:5/29/2015)... “In the current environment of opiate ... we provide education that will help practitioners address ... from pain, within the boundaries of the guidelines ... rehabilitation medicine and President/Medical Director of the International ... A new flight of PAINWeekEnd Regional Conferences offers ...
(Date:5/29/2015)... M3 USA MDLinx.com, source of the “ ... now offers The Smartest Rheumatologist . The Smartest ... ranging from Fibromyalgia and Osteoporosis, to Arthritis and Gout. ... and Caroline Tredway, editorial head of The Smartest Doc ... on the physicians who participate. Says Tredway, “With so ...
(Date:5/29/2015)... The science of Follicular Unit Extraction (FUE) ... efficient methods of FUE hair transplantation have increased the amount ... most cutting edge hair transplant methods being used to great ... extracting hair from the beard to the scalp. , Most ... male pattern baldness. Beard hair has a life cycle, ...
(Date:5/29/2015)... Jan Wooden Howse lost her husband and her ... else: God does no wrong. , It’s fitting, then, that ... is titled “God Does No Wrong.” It focuses on what ... tragedy. , “My story has a positive message about ... something productive, something healing,” Howse said. , “God Does No ...
Breaking Medicine News(10 mins):Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:MDLinx Launches Smartest Rheumatologist 2Health News:Beard to Scalp Hair Transplant: Newest Advance in Hair Transplant Technology 2Health News:Turning grief from a child’s passing into virtue 2
... THRM ), a leader in non-invasive tissue ... will present at the 2008 Maxim Group,Growth Conference. ... Time on Tuesday, October 7, 2008. Stephen J. ... the company,s business,strategy and historical financial results., ...
... Share Exchange Offer to the Holders of the Following Securities, ... JNJ, The K&N Value Select Corporation offers the holders of ... change into 1 share of,K&N Value Select Corp. - ISIN: CH0006603085 ... October 2008 and ends on 27th November,2008., K&N Value Select ...
... pleased to recognize the Association for Healthcare Resource and Materials ... 5-11. This week is dedicated to acknowledging and celebrating ... healthcare and the overall success of the healthcare supply chain. ... ...
... System To Reduce Claim Fraud and Costs by ... ILOG(R) (Nasdaq:,ILOG, Euronext: ILO, ISIN: FR0004042364) today announced ... in Argentina, is using ILOG,JRules(R) to automate its ... Swiss Medical has been able to reduce,unnecessary medical ...
... often seasonal allergy that affects between 10 and 20 ... a course of patient-adjusted dosing, according to new research ... Head and Neck Surgery. , During the ... allergic rhinitis, was observed in 69 patients, who were ...
... than 1 million children, Stores raise funds for Vitamin ... Quarters found in the,bottom of purses, pockets, and even on ... needy children. The Vitamin Shoppe is asking,everyone to donate their ... a,child., Affecting up to 140 million children every year, ...
Cached Medicine News:Health News:Broadlane Recognizes AHRMM National Healthcare Resource and Materials Management Week 2Health News:Broadlane Recognizes AHRMM National Healthcare Resource and Materials Management Week 3Health News:Swiss Medical Group Selects ILog JRules to Streamline Claims Processing 2Health News:Swiss Medical Group Selects ILog JRules to Streamline Claims Processing 3Health News:Hay fever may be best treated with self-adjusted dosing 2Health News:Spare Change Can Help Save the Life of a Child 2Health News:Spare Change Can Help Save the Life of a Child 3
(Date:5/29/2015)... May 29, 2015 Educating the community ... Association for the Advancement of Wound Care (AAWC), ... support from AAWC,s corporate partners, the Association provides ... on the AAWC website at http://aawconline.org/education-for-the-generalist/ . ... pathway with links to various CME/CEU educational programs. ...
(Date:5/28/2015)... May 28, 2015 ... the addition of Jain PharmaBiotech,s new report  ...  to their offering.       (Logo: ... gene silencing involves the use of double ... this material is processed into short 21-23 ...
(Date:5/28/2015)... , May 28, 2015 The controversy ... )  in hysterectomies and myomectomies (procedures to remove uterine ... the FBI is investigating Johnson & Johnson,s Ethicon, ... of the devices. According to the report published ... th , the FBI is trying to determine ...
Breaking Medicine Technology:The Association for the Advancement of Wound Care Educates the Public 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3
... VIRGINIA BEACH, Va., July 8, 2011 The Amerigroup ... check to the Rx Partnership to benefit the Rockbridge ... is an organization that works to provide uninsured Virginians ... as a broker to access and distribute free bulk ...
... Novartis Pharmaceuticals Corporation ("Novartis") announced today Phase III ... patients taking Afinitor® (everolimus) tablets* experienced a 50% ... subependymal giant cell astrocytomas (SEGAs), non-cancerous brain tumors ... the largest prospective clinical trial to date in ...
Cached Medicine Technology:Amerigroup Foundation Presents Grant to Rx Partnership 2Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis 2Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis 3Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis 4Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis 5Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis 6Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis 7Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis 8Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis 9Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis 10Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis 11Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis 12Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis 13
The °CureWrap is one-piece garment offers maximum available surface coverage, while avoiding the sterilized fields of operation....
... Antibody (IgG) Test is a semiquantitative enzyme ... significant IgG antibodies to M. pneumoniae between ... test should not be used for specimens ... (IgM) Test and is not intended for ...
... Test is a qualitative enzyme immunoassay ... Epstein-Barr virus capsid antigen (EBV-VCA), Epstein-Barr ... and Toxoplasma. When used in conjunction ... aid in the serodiagnosis of infectious ...
... Test is an enzyme immunoassay ... the presence of antibodies to ... and herpes simplex virus in ... to indicate previous or current ...
Medicine Products: